US health regulators are warning doctors and patients about safety issues with two separate Boston Scientific heart devices.

While neither warning is classified as a recall, the FDA has provided additional information for the two products. Boston ...

The FDA has issued an early communication to warn of updated instructions for use for certain Boston Scientific Watchman access systems.

The FDA has issued an alert regarding a safety concern with certain Boston Scientific defibrillator leads used in implantable cardioverter defibrillators. The affected models include Endotak Reliance, ...

Key Takeaways Two Boston Scientific heart devices have been linked to serious injuries and deathsOne device may fail to ...

Boston Scientific Corporation (NYSE:BSX) Q2 2025 Earnings Call Transcript July 23, 2025 Boston Scientific Corporation beats earnings expectations. Reported EPS is $0.75, expectations were $0.725 ...

The U.S. FDA expanded the approval for use of Boston Scientific Corp.’s Watchman Flx and Watchman Flx Pro left atrial appendage closure (LAAC) devices to include post-ablation patients, bringing good ...

Boston Scientific shares have increased 15% since the beginning of the year, while the S&P's 500 index has increased slightly more than 7%. The stock has increased 32% in the last 12 months.

Boston Scientific raised its annual profit forecast on Wednesday, banking on strong demand for its heart devices, and trimmed its expectation for tariff-related costs to half of the previously ...

About Boston Scientific Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world.

Boston Scientific (NYSE:BSX) is set to announce its earnings on Wednesday, July 23, 2025.

Boston Scientific Corporation (NYSE:BSX) is one of the biggest medical device companies in the world. Its shares have gained 18.9% year to date, with July proving to be a good month.